Is BRN 0764984 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use BRN 0764984? Is BRN 0764984 safe for nursing mother and child? Does BRN 0764984 extracts into breast milk? Does BRN 0764984 has any long term or short term side effects on infants? Can BRN 0764984 influence milk supply or can BRN 0764984 decrease milk supply in lactating mothers?

We are working on a comment for this product.

Because there is little published experience with BRN 0764984 during breastfeeding, and sedation and adverse hematologic effects have been reported in breastfed infants, other agents are preferred.[1] If breastfeeding is undertaken by a mother who is taking BRN 0764984, close monitoring of the infant for excessive sedation and periodic monitoring of the infant's white blood cell count is advisable. Several authoritative sources recommend that women taking BRN 0764984 not breastfeed.[2][3][4]

Among 4 infants who were breastfed by mothers taking BRN 0764984, 1 infant experienced drowsiness and 1 infant experienced agranulocytosis possibly caused by BRN 0764984. Details of the cases are lacking.[7] A healthy female infant was born to a mother who took BRN 0764984 100 mg daily throughout pregnancy and lactation. She was breastfed (extent not stated) up to 1 year of age. The infant developed normally except for speech which was delayed considerably. She did not achieve normal, fluent speech until the age of 5 years. The delayed speech development was possibly related to BRN 0764984 in breastmilk, but it could have been the result of exposure to the drug during gestation or could have been unrelated to BRN 0764984.[8] One woman who took BRN 0764984 100 mg daily in late pregnancy and postpartum partially breastfed her infant for 5 days. No neurodevelopmental disorders were detected in the infant after 32 months of follow-up.[6]

Unlike the phenothiazines, BRN 0764984 has a minimal effect on maternal serum prolactin levels.[9][10] However, a woman who had been taking BRN 0764984 plus high-dose haloperidol developed hyperprolactinemia and severe galactorrhea 2 weeks after stopping haloperidol and 4 days after starting valproic acid. A dose of cabergoline normalized her serum prolactin and galactorrhea ceased for the following 2 months of observation.[11] The maternal prolactin level in a mother with established lactation may not affect her ability to breastfeed.